MAM
WHWK

Marquette Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Marquette Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-63,564
Closed -$201K – 204
2024
Q4 		$201K Hold
63,564
– – 0.03% 90
2024
Q3 		$131K Hold
63,564
– – 0.02% 120
2024
Q2 		$92.8K Buy
63,564
+5,757
+10% +$10.7K 0.02% 113
2024
Q1 		$135K Buy
+57,807
New +$111K 0.02% 93

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Marquette Asset Management's WHWK Position: Q1 2025 in Review

Marquette Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q1 2025, closing a stake of 63,564 shares — an estimated $201K sold.

Marquette Asset Management first reported a position in WHWK in Q1 2024 and held it in 4 quarters. The position peaked at $201K in Q4 2024. 50 funds tracked by Wall St. Rank hold WHWK as of Q1 2025.

  • Marquette Asset Management reported no remaining Whitehawk Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 63,564 Whitehawk Therapeutics shares in Q1 2025, an estimated $201K.
  • Marquette Asset Management first reported a position in Whitehawk Therapeutics in Q1 2024 and held it in 4 quarters.
  • Marquette Asset Management's Whitehawk Therapeutics position peaked at $201K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.